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AbstrACt
Objectives To explore patients’ or parents of child 
patients’ understanding of antibiotic resistance and 
aspects of resistance such as resistance reversibility and 
its spread among those in close proximity, along with how 
this may influence attitudes towards antibiotic use for 
acute respiratory infections (ARIs).
Design Qualitative semistructured interview study using 
convenience sampling and thematic analysis by two 
researchers independently.
setting General practices in Gold Coast, Australia.
Participants 32 patients or parents of child patients 
presenting to general practice with an ARI.
results Five themes emerged: (1) antibiotic use is seen 
as the main cause of antibiotic resistance, but what it is 
that becomes resistant is poorly understood; (2) resistance 
is perceived as a future ‘big problem’ for the community, 
with little appreciation of the individual impact of or 
contribution to it; (3) poor awareness that resistance can 
spread between family members but concern that it can; 
(4) low awareness that resistance can decay with time and 
variable impact of this knowledge on attitudes towards 
future antibiotic use and (5) antibiotics are perceived 
as sometimes necessary, with some awareness and 
consideration of their harms.
Conclusions Patients’ or parents of child patients’ 
understanding of antibiotic resistance and aspects of it 
was poor. Targeting misunderstandings about resistance in 
public health messages and clinical consultations should 
be considered as part of a strategy to improve knowledge 
about it, which may encourage more consideration about 
antibiotic use for illnesses such as ARIs.
IntrODuCtIOn  
Antibiotics, which have been critically 
important for treating infections since 
their discovery in the 1940s, are acceler-
ating towards weakened effectiveness due 
to increase in antibiotic resistance.1 Antibi-
otic resistance, which occurs when bacteria 
change in response to the use of antibiotics 
and resist the effects of antibiotics, is largely 
driven by community antibiotic use.2–4 Anti-
biotics are prescribed more in primary care 
than other health sectors, and often for acute 
respiratory infections (ARIs), which comprise 
approximately 10% of primary care consul-
tations.5 Because of high prescribing rates, 
particularly for common conditions where 
antibiotics provide little benefit such as sore 
throat,6 acute otitis media (AOM)7 and bron-
chitis,8 primary care is targeted for reducing 
antibiotic prescribing.
Understanding patients’ beliefs about anti-
biotics and reasons for using and not using 
them can help inform interventions and 
public campaigns that aim to encourage 
appropriate antibiotic use.9 Research has 
revealed that patients overestimate the bene-
fits of antibiotics for ARIs,10 and their expec-
tations can influence antibiotic prescribing.11
Research that has explored the public’s 
understanding of antibiotic resistance, conse-
quences of it, and whether patients consider 
the threat of resistance when deciding, 
ideally in conjunction with their clinician, 
whether to use antibiotics is scarce.9 12 There 
are also aspects of antibiotic resistance that 
might affect perceptions about antibiotic 
strengths and limitations of this study
 ► Thematic analysis was performed by two research-
ers independently.
 ► To our knowledge, this is the first study to explore 
patients’ knowledge of the spread of antibiotic re-
sistance between those in close proximity and its 
decay with time.
 ► Sample unlikely to be representative of the wider 
Australian population or illnesses.
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use, but patients’ understanding of and views about these 
have not been investigated. This includes that antibiotic 
use increases resistance in the period following use, but 
this resistance decays with time,4 and that resistance can 
be transmitted between people in close proximity such 
as family and household members.13 How knowledge of 
this might influence patients’ beliefs about antibiotic use 
for minor self-limiting illnesses such as ARIs is unknown. 
Such information is needed to ensure that clinical consul-
tations and public health campaigns about antibiotic use 
cover all the appropriate and relevant key messages.
This study aimed to explore, in a sample of patients, 
or parents of child patients, presenting to a general prac-
titioner (GP) directly after the decision-making point 
in a clinical encounter for ARI, their understanding 
of: (1) antibiotic resistance in general and (2) aspects 
of antibiotic resistance, including resistance decay and 
spread among people in close proximity, and how atti-
tudes towards antibiotic use may be influenced by this 
understanding.
MethODs
Design
This was a qualitative study which used semistructured 
interviews to explore participants’ understanding of anti-
biotic resistance and implications for decisions about 
antibiotic use.
Participants and setting
Recruitment and the interviews occurred in general prac-
tices in Southeast Queensland, Australia that had been 
recruited as part of an ongoing cluster randomised trial.14 
The trial intervention that was provided to the general 
practices was three patient decision aids (for AOM), 
acute sore throat and acute bronchitis) and a 15 min 
video that demonstrated shared decision-making. Prac-
tices randomised to the control group did not receive any 
active intervention.
Recruitment of participants for this study occurred 
between September 2016 and June 2017 from both the 
intervention and control practices. Practice managers’ 
approvals were obtained through email communica-
tion and recruitment days were organised according 
to each practice’s preference. Patients were eligible to 
participate if they met these criteria. The first was that 
they were an adult (or parent of a sick child) 18 years or 
older consulting a consenting GP with one of three ARIs 
(AOM, acute sore throat, acute bronchitis) for the first 
time for that illness episode. We recruited adults and chil-
dren as both experience ARIs and with a few exceptions, 
the benefits and harms of antibiotics for ARIs, along with 
the risk and consequences of antibiotic resistance, are 
similar for both groups. Other criteria were that partic-
ipants could understand and read English and provide 
written informed consent.
Patient and public involvement
No patients or members of the public were involved in 
the design of this study. However, they were involved in 
the development of the decision aids used by GPs in some 
of the recruited general practices. Patients were involved 
in this study as participants. The results of this study were 
disseminated to interested study participants by email.
Procedure
The interviews were conducted by one author (MB), using 
an interview topic guide (summarised in box 1). The 
topic guide was developed based on a systematic review of 
relevant literature,12 and findings from a cross-sectional 
study of Australian parents’ experiences of ARI manage-
ment and antibiotic use in primary care.10 The questions 
were piloted with two eligible participants who were not 
recruited into the study, and minor rephrasing of some 
questions occurred after piloting.
Some practices organised a room for the interviews, 
whereas at other practices, the interviews occurred in 
a private area of the waiting room. The recruitment 
process differed according to each practice’s preference. 
At some practices, the interviewer (assisted by practice 
staff) approached only patients who were waiting to see 
the GPs who were participating. At other practices, the 
interviewer approached all waiting patients and asked if 
they were waiting to see one of the participating GPs (GP 
names were listed and shown to patients). If so, recruit-
ment proceeded. Patient eligibility was determined by 
asking the patients if they were suffering from one of 
the following symptoms (sore throat, cough, ear pain), 
with the diagnosis confirmed afterwards by the treating 
GP. Potential participants were provided with a verbal 
explanation of the study and a written study information 
sheet. After confirming eligibility and obtaining written 
consent, each participant was interviewed for an average 
of approximately 15 min directly after leaving the consul-
tation room. Patients were interviewed directly after the 
consultation because this is: (1) for most, the time of 
decision-making about whether to take antibiotics, (2) 
important for reducing recall bias and (3) enabled face-to-
face interviews to occur. Interviews were audio recorded, 
with participants’ consent, and transcribed verbatim after-
wards. The interview recording was deleted if a patient 
was diagnosed by their GP as having an illness other than 
box 1 summary of topic guide for interviews
 ► ‘Usual’ approaches of expecting and/or using antibiotics for manag-
ing acute respiratory infections, including beliefs about necessity of 
antibiotics, their benefits and harms and other influences on deci-
sion-making about antibiotic use
 ► Understanding of the meaning of ‘antibiotic resistance’, its cause/s, 
and implications of it. (If the participant did not know what resis-
tance was, the interviewer provided a brief explanation before pro-
ceeding to next questions).
 ► Awareness that antibiotic resistance can spread between those in 
close proximity (such as family and household members) and if un-
aware, reactions to being told that it can.
 ► Awareness that antibiotic resistance can decay over time and if un-
aware, reactions to being told that it can.
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an ARI. This occurred for one recording as the patient 
had a cough from a chronic illness.
Data analysis
After 26 participants had been interviewed, a preliminary 
thematic analysis was undertaken. It was decided that data 
saturation had not occurred, and recruitment of partici-
pants continued until data saturation was obtained at 32 
participants. This was defined as when no new ideas or 
constructs emerged from two consecutive interviews.15 
Two authors (MB and EG) then independently used 
the process for thematic analysis outlined by Braun and 
Clarke.16 After familiarising themselves with the inter-
view transcripts, they generated overarching themes 
and subthemes. This was a data-driven process that was 
partially inductive in nature. The authors compared and 
discussed their themes and analyses and with the input of 
an additional researcher (TH), came to consensus. The 
themes and illustrative quotes were then agreed to by all 
authors.
results
Participant characteristics
We approached 208 patients in five general practices: 41 
met the inclusion criterion of having an ARI, and of these, 
32 (18 adult patients and 14 parents of sick children) 
consented to participate. The most common reason given 
for declining participation was insufficient time to be 
interviewed. Participants’ mean age was 38 years (range 
18–74), the majority were female (n=25, 78%) and half 
(n=16, 50%) were consulting for an episode of acute 
bronchitis (table 1).
themes
Five themes emerged, and these are presented below and 
supported by illustrative quotes.
Theme 1: antibiotic use is seen as the main cause of antibiotic 
resistance, but what it is that becomes resistant is poorly 
understood
Many participants thought that antibiotic overuse or 
misuse in people drives antibiotic resistance—‘Some-
times people think they need antibiotics. That’s where 
they can lead to resistance because they have them too 
much’ (P03); with a few mentioning other reasons such 
as antibiotic use in animals; ‘Through our food, that sort 
of thing, it does seem to be a concern now. Like, animals 
getting fed antibiotics’ (P12); or not using the full antibi-
otic course ‘But if you use them … you don’t take the full 
dose, obviously like in that you’ve got your certain bugs 
coming out.’ (P25).
Nearly all participants thought that antibiotic resistance 
is when the body becomes resistant to antibiotics:
‘Antibiotic resistance, your body is resistant to it and 
maybe you’ve used too much of it… antibiotics’ (P16)
‘Antibiotic resistance is possibly your body, rejecting 
the benefits of the antibiotics … it’s almost like the 
body gets used to the antibiotic’ (P10)
‘If you take antibiotics too regularly, your body stops, 
reacting to them, or they stop having an impact’ 
(P04)
Some participants still had misperceptions after the 
interviewer provided a simple explanation of what anti-
biotic resistance is (‘Antibiotic resistance happens when 
bacteria change to protect themselves from an antibiotic. 
They are then no longer killed by that antibiotic’):
‘Oh, yeah, see I’ve never had that sort of problem. I’ve 
never heard it. Whenever I’ve taken it, maybe I wasn’t 
sick enough to sort of resist it. It’s always worked. And 
for the time that I had to take more than once, a re-
peat, you know.’ (P23)
Theme 2: resistance is perceived as a future ‘big problem’ for the 
community, with little appreciation of the individual impact of, or 
contribution to it
Most participants perceived antibiotic resistance as 
a community problem caused by others who misuse 
antibiotics:
‘… if people are over using it. Yeah, especially with 
their children when they’re so young. If they’re regu-
larly on antibiotics, yeah….’(P06)
‘I imagine there would be some pockets of the com-
munity that it [antibiotic resistance] might be an is-
sue for.’ (P04)
‘I think it’s a big problem. People like to get antibi-
otics and just solve things instantly. Like people don’t 
like to wait and see what happens, they like to get 
something—even if they think it’s going to work or 
not, they just—something to make it better.’ (P15)
Most participants described resistance as a problem 
that will not impact them individually—‘I don’t think 
it’s a big issue for me’ (P09); ‘I think I’ll get through 
my life without it impacting on it’ (P21). A few partic-
ipants described their worry about antibiotic resistance, 
although by many it was viewed as a future or a hypothet-
ical concern:
‘Oh, huge, I don’t want that to happen… Um, well, 
if she got sick and constantly needed antibiotics… 
you know, then obviously in—as she gets older, they’d 
stop working as much as you wouldn’t be able to treat 
infections as much and I don’t want that to happen’ 
(P03)
‘… it could become a big problem if the so-called 
superbugs, um, come out and about later on, yeah.’ 
(P09)
‘It still concerns me, um, because someone as young 
as my two year-old son—I guess in an older person, it’s 
perhaps not as concerning because over the course of 
a life time. but I think the message is out there that 
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maybe you need to think twice before (using antibi-
otics)’ (P09)
Theme 3: poor awareness that resistance can spread between 
family members but concern that it can
Most participants did not know that antibiotic resistance 
can spread between people who are in close proximity, 
such as family members—‘No, I didn’t even know it could 
spread’ (P24). Some thought it would be possible:
‘Um, I’ve never really thought about it before. My 
initial answer would be no, but I guess like if—yeah 
I guess if one of the children had a bug that was 
tougher, and they gave that to the other child, then, 
yeah, I guess, yeah, I guess it would be’ (P32).
When participants were told by the interviewer that it 
can, the most common reaction was concern ‘concerned. 
Yeah, it’s not a good thing’ (P14) and shock ‘Oh, shocked. 
No, I never knew that.’ (P01), with some insight into the 
significance of the problem ‘So by one person using anti-
biotics can create problems for the whole family… Yeah. 
Well, that’s, um, not real good, is it?’ (P19)
Some participants suggested strategies to minimise the 
spread of resistance such as decreasing antibiotic use ‘…. 
Table 1 Participant characteristics
Participant ID Participant age (years) Gender Presenting condition If child patient, age (years)
P01 18 Female Sore throat
P02 73 Male Acute bronchitis
P03 34 Female Acute otitis media 
(AOM)
1
P04 47 Female Sore throat
P05 37 Female Sore throat 1.3
P06 34 Female Unspecified 
acute respiratory 
infection (ARI)
11
P07 38 Female Acute bronchitis
P08 28 Female Acute bronchitis
P09 32 Female Acute bronchitis 2
P10 22 Male Acute bronchitis
P11 27 Female Sore throat
P12 64 Male Acute bronchitis
P13 52 Male Acute bronchitis 3
P14 39 Male Acute bronchitis 2
P15 36 Female AOM 6
P16 43 Female Acute bronchitis 3
P17 18 Female Sore throat
P18 43 Female Sore throat
P19 70 Female Acute bronchitis
P20 45 Female Sore throat
P21 34 Male Acute bronchitis
P22 30 Female AOM 4
P23 74 Female Acute bronchitis
P24 25 Female Acute bronchitis 1.3
P25 24 Female Sore throat
P26 18 Female Acute bronchitis
P27 36 Female Unspecified ARI 3
P28 21 Male Unspecified ARI
P29 50 Female Unspecified ARI
P30 34 Female Acute bronchitis 2
P31 38 Female Acute bronchitis 4.5
P32 35 Female AOM 1.8
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so not using them too much’ (P03) or with hand hygiene 
(‘hand sanitiser’ (P21), ‘wash hands’ (P07)).
Theme 4: low awareness that resistance can decay with time and 
variable impact of this knowledge on attitudes towards future 
antibiotic use
Most participants did not know that antibiotic resistance 
could decay over time:
‘Oh, I’ve got no idea, I thought it just—that it stayed for 
a lifetime if you were resistant to it.’ (P24)
‘Oh, a long time. You’d have to—it’d take a lot of 
different ways to treat it’ (P03)
‘I imagine not, because once it’s in your system, it re-
mains there’ (P09)
There was wide variation on estimation of the time to 
decay, ranging from days to decades:
‘It wouldn’t be; you wouldn’t think within a couple of 
days… But I’m not saying 12 months or anything like 
that’ (P19)
‘Oh, probably ten years or something, crazy’ (P15)
After explanation from the interviewer that antibi-
otic resistance does decay, some participants were more 
hopeful about the problem of antibiotic resistance:
‘…it’s promising to know that there is a chance … giv-
en enough time, then they [Antibiotics] could work 
again’ (P21)
‘Yeah, well that’s good that it could be then revers-
ible’ (P32)
‘It makes me think that you could possibly go back to 
using those antibiotics if you had the similar problem 
maybe 18 months down the track’ (P10)
It was assumed by some that science will come up with 
solutions to manage antibiotic resistance in the future:
‘I don’t think it will go away, but I think maybe people 
are coming up with different solutions to fight it rath-
er than antibiotics or different ways of switching off 
you know our body’s responses and things like that.’ 
(P15)
‘it will be interesting over the next 10–15 years. I 
think that probably there’ll be some really good 
break throughs in—in the engineering and the sci-
ence behind antibiotics…’ (P21)
The impact of knowing about resistance decay on atti-
tude towards antibiotic use was variable. Some participants 
indicated no change (‘No different than I said before. If 
it means it’s (antibiotics) going to save my life and help 
me in my health, it wouldn’t make any difference at all. 
(P23)), whereas others expressed that knowing this made 
them more cautious:
‘That makes me really think about it—taking antibi-
otics only if you really need to’ (P08)
‘Especially for the children it would a lot scarier that 
they wouldn’t be able to be treated … if they were sick 
and something. It’s quite frightening.’ (P22)
Theme 5: antibiotics are perceived as sometimes necessary, with 
some awareness and consideration of their harms
Antibiotics were seen as beneficial by many participants 
(‘only thing that helps’ (P20)). The most commonly 
reported perceived benefits were decreased duration of 
illness (‘taking antibiotics would make me better quicker’ 
(P11)) and decreased severity or progression of the infec-
tion (‘to make sure it doesn’t go to any further stages of 
infection.’ (P06)).
Some participants believed in the need for antibiotics, 
despite being told by their GP that antibiotics would not 
help with viruses or provide better outcomes for them:
‘ …the doctor said oh it’s a virus, I said well I’m going 
to be looking after my grandchildren, it’s school hol-
idays, and I needed something to help me get over 
this. …and she said but they are not going to help 
you. I said well it’s my decision at the time to have 
them because I didn’t want my children to have what 
I had, you know. It was just a very bad virus I had, you 
know. But anyway, the antibiotics did work.’ (P23)
Some participants were reluctant to take antibiotics for 
minor self-limiting illnesses, such as ARIs, and preferred 
to reserve antibiotic use for severe infections—‘I would 
be hesitant. So, yes, maybe each time my doctor gives 
me antibiotics, I would ask is that necessary?’ (P07), with 
some concerned about not wanting to overuse antibi-
otics—‘should be more carefully applied and perhaps 
conservatively used.’ (P18). Others’ attitudes about anti-
biotic use were not influenced by illness severity—‘…
doesn’t really change my opinion of it… certain anti-
biotics really work’ (P25). Some participants’ reasons 
for not using antibiotics were to ‘give the body the best 
fighting chance’ (P15) and by ‘trying natural healing and 
staying healthy in the first place’ (P13).
The few participants who had personal experience of 
antibiotic resistance were particularly cautious about anti-
biotic use:
‘…because of my bronchitis… I have taken other 
medications that haven’t worked. The—the doctors 
then had to change it… to a different medication. 
Yeah. Because I become resistant to others so I’m very 
fussy about taking them.’ (P20)
There was great variability in participants’ awareness 
of the potential harms of antibiotics. Many participants 
named potential side effects with commonly listed ones 
including ‘vomiting’, ‘nausea’, ‘thrush’ and ‘diarrhoea’. 
Some mentioned ‘possible resistance’ as one of their 
concerns, but responses conveyed misunderstanding of 
what antibiotic resistance actually is. Some participants 
were not aware that antibiotics had potential harms—
‘None that I’m aware of’ (P21).
The patient–clinician relationship was viewed as very 
important when decisions about the management of 
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infections were being made. Trust in the clinicians’ 
recommendation for antibiotic use was mentioned by 
some—‘as long as I can talk to my doctor and trust that 
the doctor is making the right decision’ (P05).
Some participants described a lack of information and 
discussion with their clinician ‘I don’t have enough infor-
mation to probably correctly make that call.’ (P18) and 
were unaware of the option to not treat with antibiotics 
(that is, that the illness would get better without them) 
‘Um, well I guess when it’s infected there’s not really 
much other choice for that particular problem’ (P32).
Some expressed a desire for more information about 
antibiotic resistance:
‘Um, yeah, it would be good to know more about, 
um, how often you have to be taking them for resis-
tance to build, whether individual, patient to patient’ 
(P18).
‘… interested in knowing more information about 
(antibiotic resistance)’ (P15)
DIsCussIOn
This study has identified five major themes that related 
to people’s understanding of antibiotic resistance and 
aspects of resistance such as resistance reversibility and 
spread among those in close proximity such as family or 
household members. While many participants articulated 
the link between antibiotic use and resistance, there was 
confusion about the nature of antibiotic resistance, which 
was often attributed to a trait of the body rather than 
bacteria in the microbiome. Many saw antibiotic resis-
tance as a potential problem, rather than one that exists 
already, and that it was a consequence of and problem 
for the others in the community rather than them as an 
individual. Few appreciated the potential for antibiot-
ic-resistant organisms to spread between those in close 
proximity, or that antibiotic resistance can decay.
Most participants reported the main benefit of anti-
biotic use was a decreased duration of illness. Some 
were aware of the potential for harm from antibiotics, 
including resistance. Some expressed reluctance to use 
antibiotics for minor self-limiting infections because of 
concern about overuse or misuse, whereas for others, it 
was not because of the potential harms but because of a 
preference for allowing their body to fight the infection 
naturally.
The poor understanding of the nature of antibiotic 
resistance has been found in previous studies in a general 
practice setting17 and in non-healthcare settings.18–20 A 
recent survey of the UK general adult population showed 
that lack of antibiotic resistance awareness was strongly 
associated with self-reported likelihood of requesting 
antibiotics for an influenza-like infection.21 It appeared 
that patients who had personal experience of antibiotic 
resistance were the most reluctant to use them again, 
preferring to reserve their use for serious illness. A survey 
of the general population in Germany found that people 
who knew of someone suffering from multidrug-resistant 
organisms, received more information by their clinician 
on antibiotic resistance and took less antibiotics for an 
infection (of any cause), compared with people who did 
not have any personal involvement.19
Our finding that the lack of individual ‘ownership’ 
of contribution to, or risk of, antibiotic resistance has 
previously been identified in a systematic review,12 which 
showed that the public do not believe they contribute 
to the development of antibiotic resistance. This is 
complemented by the finding that some participants 
believe that science will find a way to solve the resistance 
problem, which contradicts with messages about individ-
uals needing to change their behaviour to minimise the 
problem.
Many public health campaigns convey the message 
of antibiotic resistance and how it is promoted by inap-
propriate antibiotic use and misuse. The effect of some 
campaigns has been analysed and a decrease in antibiotic 
use was found.22 23 Some of our findings might be useful 
in guiding and refining the content of messages in public 
health campaigns and clinical consultations about antibi-
otic resistance. For example, the information that devel-
oping antibiotic resistance in one’s microbiome might 
also lead to resistance in people who are physically close 
to them, such as family members, could be an additional 
message in patient and public educational strategies to 
encourage appropriate antibiotic use. Most participants 
were quite concerned on learning about resistance 
spread and it prompted some to provide suggestions for 
how to minimise resistance development and its spread—
suggesting that perhaps this is the information that could 
contribute to altering people’s attitudes and behaviour 
about antibiotic use for minor self-limiting illnesses.
Future research into the optimal information about 
antibiotic use and resistance to include in public messages 
and clinical consultations is recommended. This includes 
the potential utility of information about resistance decay 
and its impact on antibiotic use. Knowing that resistance 
decays over time if antibiotics are not used promoted 
hope in some people that the problem of resistance was 
not irreversible and that efforts to conserve antibiotic 
effectiveness by not using unless essential are worthwhile. 
However, for others, knowing that resistance decay occurs 
over time, may thwart attempts to encourage responsible 
antibiotic use.
At a clinical consultation level, better engagement 
with patients when antibiotics are being considered by 
providing a balanced discussion of antibiotic benefits and 
harms is encouraged. This conversation should include 
discussion that resistance is a potential harm of antibiotic 
use, and explanation of the possible consequences of it 
for the individual and the broader community.
A limitation of our study is that the sample is not 
representative of the wider Australian population as 
participants were recruited from one city in Australia, 
only those presenting with an ARI were invited, and the 
majority of participants were female. For a small number 
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of participants (9), there is the risk that their knowledge 
about antibiotic resistance was influenced by their GPs’ 
use of a patient decision aid—which included a very 
brief explanation of what resistance is, but not about the 
spread or decay of resistance. Although GPs who did not 
receive or use the aids may have mentioned resistance as 
part of the consultation regardless. Other limitations are 
that participants did not have the opportunity to provide 
feedback on the themes derived from the interviews 
and the short duration of the interviews—which could 
have affected the depth of the gathered information. 
Strengths of the study include the use of two researchers 
independently performing the thematic analysis and its 
contribution of new findings to this field. We are not aware 
of other studies which have explored people’s knowledge 
about the potential for antibiotic-resistant organisms to 
spread between those who are in close proximity or that 
antibiotic resistance decays over time.
COnClusIOn
This study found that patients’ understanding of many 
aspects of antibiotic resistance was poor including: what 
it is, individual contribution to its development, indi-
vidual implications, its spread and decay. Incorporating 
messages that target misunderstandings into public health 
messages and clinical consultations may be an important 
strategy to encourage more appropriate use of antibiotics 
for illnesses such as ARIs.
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